BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 18512025)

  • 1. Abnormal cytokine production by bone marrow stromal cells of multiple myeloma patients in response to RPMI8226 myeloma cells.
    Zdzisińska B; Bojarska-Junak A; Dmoszyńska A; Kandefer-Szerszeń M
    Arch Immunol Ther Exp (Warsz); 2008; 56(3):207-21. PubMed ID: 18512025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of cytokine production in 2-dimensional and 3-dimensional cultures of bone marrow stromal cells of multiple myeloma patients in response to RPMI8226 myeloma cells.
    Zdzisińska B; Roliński J; Piersiak T; Kandefer-Szerszeń M
    Folia Histochem Cytobiol; 2009; 47(1):69-74. PubMed ID: 19419941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysregulation of the receptor activator of NF-kappaB ligand and osteoprotegerin production influence the apoptosis of multiple myeloma patients' bone marrow stromal cells co-cultured with myeloma cells.
    Zdzisińska B; Bojarska-Junak A; Walter-Croneck A; Kandefer-Szerszeń M
    Arch Immunol Ther Exp (Warsz); 2010 Apr; 58(2):153-63. PubMed ID: 20157786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of B-cell-activating factor in adhesion and growth of human multiple myeloma cells in the bone marrow microenvironment.
    Tai YT; Li XF; Breitkreutz I; Song W; Neri P; Catley L; Podar K; Hideshima T; Chauhan D; Raje N; Schlossman R; Richardson P; Munshi NC; Anderson KC
    Cancer Res; 2006 Jul; 66(13):6675-82. PubMed ID: 16818641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormalities of bone marrow mesenchymal cells in multiple myeloma patients.
    Wallace SR; Oken MM; Lunetta KL; Panoskaltsis-Mortari A; Masellis AM
    Cancer; 2001 Apr; 91(7):1219-30. PubMed ID: 11283920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor beta receptor I kinase inhibitor down-regulates cytokine secretion and multiple myeloma cell growth in the bone marrow microenvironment.
    Hayashi T; Hideshima T; Nguyen AN; Munoz O; Podar K; Hamasaki M; Ishitsuka K; Yasui H; Richardson P; Chakravarty S; Murphy A; Chauhan D; Higgins LS; Anderson KC
    Clin Cancer Res; 2004 Nov; 10(22):7540-6. PubMed ID: 15569984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Both myeloma cells and bone marrow stromal cells are involved in the overproduction of interleukin 6 in multiple myeloma].
    Ding S; Hou J; Sun A
    Zhonghua Xue Ye Xue Za Zhi; 1998 Jun; 19(6):306-8. PubMed ID: 11243111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applications.
    Gupta D; Treon SP; Shima Y; Hideshima T; Podar K; Tai YT; Lin B; Lentzsch S; Davies FE; Chauhan D; Schlossman RL; Richardson P; Ralph P; Wu L; Payvandi F; Muller G; Stirling DI; Anderson KC
    Leukemia; 2001 Dec; 15(12):1950-61. PubMed ID: 11753617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of thalidomide on Bcl2 expression and proangiogenic cytokine levels in short-term culture of peripheral blood and bone marrow mononuclear cells of multiple myeloma patients.
    Dmoszyńska A; Roliński J; Bojarska-Junak A; Mańko J; Jawniak D; Walter-Croneck A; Soroka-Wojtaszko M; Hus M
    Pol J Pharmacol; 2001; 53(6):709-13. PubMed ID: 11985351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-cell contact between marrow stromal cells and myeloma cells via VCAM-1 and alpha(4)beta(1)-integrin enhances production of osteoclast-stimulating activity.
    Michigami T; Shimizu N; Williams PJ; Niewolna M; Dallas SL; Mundy GR; Yoneda T
    Blood; 2000 Sep; 96(5):1953-60. PubMed ID: 10961900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow stromal-derived soluble factors and direct cell contact contribute to de novo drug resistance of myeloma cells by distinct mechanisms.
    Nefedova Y; Landowski TH; Dalton WS
    Leukemia; 2003 Jun; 17(6):1175-82. PubMed ID: 12764386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The interaction of vascular endothelial growth factor and interleukin-6 in multiple myeloma].
    Zhang L; Chen SL; Chen WM; Liu JW
    Zhonghua Nei Ke Za Zhi; 2005 Feb; 44(2):85-8. PubMed ID: 15840215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinase and cytokine production by bone marrow adherent cells from multiple myeloma patients.
    Zdzisińska B; Walter-Croneck A; Dmoszyńska A; Kandefer-Szerszeń M
    Arch Immunol Ther Exp (Warsz); 2006; 54(4):289-96. PubMed ID: 16868721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interdependence between cytokines and cell adhesion molecules to induce interleukin-6 production by stromal cells in myeloma.
    Thomas X; Anglaret B; Magaud JP; Epstein J; Archimbaud E
    Leuk Lymphoma; 1998 Dec; 32(1-2):107-19. PubMed ID: 10037006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unique biomechanical interactions between myeloma cells and bone marrow stroma cells.
    Feng Y; Ofek G; Choi DS; Wen J; Hu J; Zhao H; Zu Y; Athanasiou KA; Chang CC
    Prog Biophys Mol Biol; 2010 Sep; 103(1):148-56. PubMed ID: 19840813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zoledronic acid down-regulates adhesion molecules of bone marrow stromal cells in multiple myeloma: a possible mechanism for its antitumor effect.
    Corso A; Ferretti E; Lunghi M; Zappasodi P; Mangiacavalli S; De Amici M; Rusconi C; Varettoni M; Lazzarino M
    Cancer; 2005 Jul; 104(1):118-25. PubMed ID: 15895374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of the cytokine network in multiple myeloma: diagnostic, prognostic, and therapeutic implications.
    Lauta VM
    Cancer; 2003 May; 97(10):2440-52. PubMed ID: 12733143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paracrine interactions of basic fibroblast growth factor and interleukin-6 in multiple myeloma.
    Bisping G; Leo R; Wenning D; Dankbar B; Padró T; Kropff M; Scheffold C; Kröger M; Mesters RM; Berdel WE; Kienast J
    Blood; 2003 Apr; 101(7):2775-83. PubMed ID: 12517814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of anti-myeloma activity of interleukin-2 activated bone marrow in vitro].
    Liu W; Chen SL; Liu JW; Li X; Xia CQ; Qi M
    Zhonghua Xue Ye Xue Za Zhi; 2005 Apr; 26(4):205-8. PubMed ID: 15949260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble IL-6R alpha upregulated IL-6, MMP-1 and MMP-2 secretion in bone marrow stromal cells.
    Barillé S; Collette M; Thabard W; Bleunven C; Bataille R; Amiot M
    Cytokine; 2000 Sep; 12(9):1426-9. PubMed ID: 10976008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.